Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 1,641–1,648 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Enanta Pharmaceuticals Inc. EDP-235 - (SPRINT) COVID-19 Phase 2 Data Released oral COVID-19
enGene Holdings Inc. Detalimogene voraplasmid (EG-70) - (LEGEND) BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) BLA Filing Data Released Intravesical Oncology
Enliven Therapeutics Inc. Tovinontrine (IMR-687) Heart failure with preserved ejection fraction (HFpEF) Phase 2 Trial Discontinued Oral Cardiology
Enliven Therapeutics Inc. Tovinontrine (IMR-687) - (Forte) b-thalassemia Phase 2b Trial Discontinued Oral Genetic Disorder
Enliven Therapeutics Inc. Tovinontrine (IMR-687) - (Ardent) Sickle cell disease (SCD) Phase 2b Trial Discontinued oral Hematology
Enliven Therapeutics Inc. Tovinontrine (IMR-687) Sickle cell disease Phase 2a Trial Discontinued Oral Hematology
Enlivex Therapeutics Ltd. Allocetra - (ENX-CL-05-001) Knee osteoarthritis (OA) Phase 2a Data Released Intravenous Orthopedic
Enlivex Therapeutics Ltd. Allocetra COVID-19 Phase 2b Trial Discontinued Intravenous COVID-19
1…204205206207208…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.